WORCESTER, Mass.--(EON: Enhanced Online News)--James Gagnon, PharmD, director of Clinical Services for UMass Medical School Clinical Pharmacy Services, has been named president of the Massachusetts Pharmacists Association (MPhA).
Gagnon, who will serve a one-year term as president, was installed at the MPhA’s 130th annual awards banquet last month, held during the New England Pharmacists Convention in Mashantucket, Conn.
In his acceptance speech, Gagnon touched on the timely topic of sterile compounding pharmacies in Massachusetts, and the critical role that pharmacists play in ensuring public safety and patient access to important medications. He also said that he looks forward to leading MPhA's public policy efforts on a number of fronts, including securing healthcare provider status for pharmacists and extending authorization for trained pharmacy interns to administer vaccines.
In his position with UMass Medical School, Gagnon is responsible for supervising clinical pharmacy support including therapeutic class and new drug reviews, utilization management strategies and leading quality assurance initiatives for Clinical Pharmacy Services’ clients. Among the organizations served by the program are health care provider and payer organizations such as Health New England, Neighborhood Health Plan of Massachusetts; and the Medicaid programs for Massachusetts (MassHealth), Alabama, Nevada and Vermont (Department of Vermont Health Access).
A key client project for Gagnon and his team over the past year has been working with Commonwealth Care Alliance on the development and implementation of a pharmacist-run medication therapy management program for Medicare Part D.
About the University of Massachusetts Medical School
The University of Massachusetts Medical School, one of the fastest-growing academic health sciences centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $255 million in research funding annually, 80 percent of which comes from federal funding sources. The mission of the Medical School is to advance the health and well-being of the people of Massachusetts and the world, through pioneering education, research, public service and health care delivery. Commonwealth Medicine, the Medical School’s health care consulting and operations division, provides a wide range of care management and consulting services to government agencies and health care organizations. For more information, visit commed.umassmed.edu.